New imaging methods provide unprecedented close-up view of cilia linked to blindness

A new study published today by researchers from Baylor College of Medicine and UT Health's McGovern Medical School in the Proceedings of the National Academy of Sciences reveals an unprecedented close-up view of cilia linked to blindness. Cilia are short hair-like structures found on the surface of certain cells. They are particularly important in vision because they work as light sensors and defects in their structure can lead to retinal degeneration and loss of vision. Studying cilia structural alterations has previously been limited to the resolution capacity of traditional imaging technologies.

In the current study, researchers reported the development and application of new imaging methods that provided a higher resolution view of the internal structure of normal and diseased retinal cilia. They discovered previously unknown compartments within the cilia and the location of some of the proteins involved in retinal disease. Their findings contribute to a better understanding of the structural defects leading to cilia-related blindness and open the door to developing future therapies.

There is a large group of diseases called ciliopathies that are caused by genetic defects in the components of the structure of cilia. One the most common symptoms of ciliopathies is retinal degeneration and blindness, such as seen in retinitis pigmentosa and Bardet-Biedl syndrome."

Dr. Theodore G. Wensel, corresponding author, professor and Robert A. Welch Chair in Chemistry in the Department of Biochemistry at Baylor

Wensel and his colleagues wanted to better understand how the genetic defects liked to retinal ciliopathies affected the structure of the cilia. But cilia are tiny, and the methods that have traditionally been used to study structural changes do not have enough resolution to reveal details of cilia internal structure.

"We wanted to look inside cilia to see how the molecules known to be involved in the disease caused the defects," Wensel said. "We developed new methods - cryoelectron tomography and STORM (super-resolution stochastic optical reconstruction microscopy) - that provided a nanoscale view of the internal structure of the cilia. We worked with normal mice and mouse models of the human disease, Bardet-Biedl syndrome."

The researchers applied these methods first to determine the structure of cilia in normal retina and found sub-compartments that had not been seen before. When they applied their higher resolution techniques to diseased retinas, they were able to pinpoint a more precise location of proteins associated with the condition.

"Before, we could say that a particular protein encoded by a disease gene was located at the cilium. Now we can say that it is located in the center of the axon, which is a tiny structure located in the center of the cilium, or in another of the newly discovered compartments," Wensel said.

The researchers also discovered that some of the genetic defects alter the location of some of the proteins in the structure, and this information can potentially be useful to design therapies.

"Our findings provide a more detailed look at the structural changes associated with cilia defects in Bardet-Biedl syndrome. Our hope is that by understanding the disease mechanisms better we can develop therapies for this and other related conditions," Wensel said.

Source:
Journal reference:

Robichaux, M.A., et al. (2019) Defining the layers of a sensory cilium with STORM and cryoelectron nanoscopy. Proceedings of the National Academy of Sciences. doi.org/10.1073/pnas.1902003116.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Evo model set to transform synthetic biology and disease diagnosis